Skip To Main Content
Ananthi Anandhakrishnan on Muck Rack

Ananthi Anandhakrishnan

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ananthi

Contact Ananthi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy - Nature Medicine

|
By Jane Speight, Sufyan Hussain, Ananthi Anandhakrishnan, Thomas Danne, Esther Latres, Stephen R. Karpen, Linxi Mytkolli, Renza Scibilia, Uffe Soeholm, Peter A. Senior
| Nature Verified
Stem-cell-derived islet cells could transform type 1 diabetes by removing the need for injected or infused insulin and improving quality of life. But evaluation of these therapies must center on the voices of people living with type 1 diabetes and examine meaningful outcomes.
Open in Who Shared Issue with article?

Discordant real‐world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter

|
By Panagiotis Pavlou, Ananthi Anandhakrishnan, Kleoniki I. Athanasiadou, Anna Brackenridge
| Wiley Online Library Verified
1 BACKGROUND Hybrid closed loop (HCL) systems are the most advanced form of insulin therapy currently available for people with type 1 diabetes (pwT1D). However, despite their increasing use in clinical practice, there is a paucity of real-world studies comparing different HCL systems. To help address this evidence gap, we conducted a real-world observational study comparing Omnipod™ 5 (OP-5) with Medtronic MiniMed™ 780G (MT780G) in pwT1D.
Open in Who Shared Issue with article?

Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes

|
By Ananthi Anandhakrishnan, Sufyan Hussain, Ananthi Anandhakrishnan MRCP, Sufyan Hussain MRCP
| Wiley Online Library Verified
1 INTRODUCTION Despite advances in the management of type 1 diabetes (T1D), the daily decision-making burden in the pursuit of optimizing glycaemia is significant. Therefore, it is not surprising, that for many living with T1D, glycaemia remains above the recommended targets.
Open in Who Shared Issue with article?
See all 4 licensed articles (5 Total)